Limitless X Holdings Inc.

What they do

Limitless X, Inc., the primary commercial engine, runs a direct-to-consumer e-commerce platform offering dietary supplements and consumer packaged goods across direct-to-consumer, Amazon, and retail channels. The portfolio centers on the NZT-48 line (Original, Lion's Mane, For Her, NAD+ Gummies) plus OneShot Nootropic Pre-Workout, SuperSlim Gummies, HYDR8 Creatine + Hydration Gummies, SuperShrooms Functional Mushroom Gummies, Super Greens Daily Greens, and Nootropic Coffee Concentrates. Limitless Films develops, packages, finances, and monetizes film and television content, and Limitless Entertainment Group pursues pro boxing and combat sports through live events, fighter development, and media. BodyCor is the technology and data layer, and in January 2026 the Company acquired a 60% controlling interest in DING, a food and nutrition technology platform with an Instacart commercial partnership.

Revenue drivers

• Limitless X supplements (direct-to-consumer, Amazon, retail) — Described as the Company's primary commercial engine and the source of essentially all reported revenue; the NZT-48 line is the flagship. Total annual revenue fell from $39.9M in 2022 to $15.5M in 2023, $3.4M in 2024, and $946,563 in 2025, so this channel has been shrinking.
• Celebrity signature supplement lines — The Company has agreements to develop signature premium supplement lines for Manny Pacquiao and Paul Michael DelVecchio Jr. (DJ Pauly D). These are described as planned or in-development and no related revenue is broken out in the filings.
• Film content (Limitless Films) — Limitless Films handles development, packaging, financing, and monetization of film and TV content; in 2025 the Company was involved in financing two films, The Gentleman Thief and High Rollers, both starring John Travolta. No film revenue figure is disclosed in the excerpts.
• Boxing and live events (Limitless Entertainment) and DING digital wellness — Limitless Entertainment covers pro boxing and combat sports events, fighter development, and media, and the Company is working on the Limitless X Manny Pacquiao Impact Performance Training Center in Los Angeles targeted for June 2026 opening. DING, 60% acquired in January 2026, is a nutrition technology platform with an Instacart partnership intended to sit under BodyCor; no revenue contribution is quantified.

Recent performance

Revenue has contracted sharply: $39.9M in 2022, $15.5M in 2023, $3.4M in 2024, and $946,563 in 2025. Quarterly revenue has continued to fall, from $247,868 in the quarter ended 2025-09-30 to $144,167 in 2025-12-31, $77,570 in 2026-03-31, and $42,206 in 2026-06-30. Net losses were $18.9M in 2022, $13.9M in 2023, $4.2M in 2024, and $46.1M in 2025, with operating cash flow negative every year and -$1.6M in 2025. At 2026-06-30 the Company reported total assets of $1.7M, total liabilities of $7.8M, and shareholder equity of -$9.2M.

Strategy

The stated strategy is to combine consumer product sales, content production, live events, and technology platforms across the four subsidiaries to support customer acquisition efficiency and revenue diversification. Management calls direct-to-consumer product sales the current primary focus while integrating DING under BodyCor to add meal planning, commerce enablement, and nutrition engagement. The Company is developing signature supplement lines with Manny Pacquiao and DJ Pauly D and pursuing international expansion in the Middle East, the Philippines, and India. It is also advancing the Limitless X Manny Pacquiao Impact Performance Training Center in Los Angeles, targeted to open in June 2026.

Risks

• Going concern uncertainty — The 10-K states that the report of the independent registered public accounting firm includes a going concern uncertainty explanatory paragraph, and at 2026-06-30 liabilities of $7.8M exceeded assets of $1.7M with negative equity of $9.2M.
• Brand ownership concentrated with the CEO — The 10-K risk factors state that all current brands and products the Company sells and promotes are owned or controlled by its Chief Executive Officer, so the Company could lose all of its business at any time.
• Persistent losses and revenue decline — The Company has incurred significant losses, expects future losses, and may not generate sufficient revenue to achieve profitability, with annual revenue falling from $39.9M in 2022 to $946,563 in 2025 and a $46.1M net loss in 2025.
• Customer acquisition and retention — The 10-K warns that failure to cost-effectively acquire new consumers or retain existing consumers, or to maintain average order value levels, would materially harm revenue and margins.

Outlook

Management describes direct-to-consumer product sales as the current primary focus and says integrating DING is intended to expand monetization through commerce-enabled partnerships and support long-term growth, operating leverage, and customer retention. The Company points to the Limitless X Manny Pacquiao Impact Performance Training Center in Los Angeles, targeted for opening in June 2026, and to international expansion in the Middle East, the Philippines, and India. It also cites celebrity-linked supplement lines with Manny Pacquiao and DJ Pauly D as portfolio additions, without providing revenue or timing guidance in the excerpts.